Celsion CORP CLSN Cash Flow

Celsion corp (CLSN)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash flows from operating activities:
Net loss
-19,540	-16,851	-8,268	-7,447	-9,773	-11,883	-22,044	-23,059	-19,719	-20,402	-21,117	-21,856	-21,497	-22,053	-22,170	-20,028	-21,172	-22,461	-23,403	-26,077	-27,076	-25,494	-22,988	-20,117	-13,023	-8,251	-12,561	-14,507	-21,033	-26,568	-24,430	-24,804	-25,644	-23,222	0	0	0
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization
721	721	632	544	458	356	302	386	469	553	1,168	1,120	1,071	1,022	460	448	436	424	436	414	391	369	370	360	349	339	350	327	304	281	201	190	180	169	0	0	0
Change in fair value of earn-out milestone liability
18	3,189	3,152	7,181	7,031	3,630	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of warrants issued in connection with amendment to modify GEN-1 earn-out milestone payments
-	-400	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Recognition of deferred revenue
0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of earn-out milestone liability
-	-	-	-	-	-	-	-	-	-	-	-	752	733	-855	89	-388	-257	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash received for non-refundable research and development fee
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,000	0	0	0	-	-	-	-	-	-	-	-
Change in fair value of common stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-1,211	-705	-8	81	0	0	0
Recognition of deferred revenue
-	-	-	-	-	-	-	-	-	-	-500	-500	-500	-500	-500	-500	-500	-500	-500	-500	-500	-500	-500	-500	-500	-500	0	0	0	-	-	-	-	-	-	-	-
Change in fair value of common stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	61	-61	-158	-158	-204	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation costs
2,047	2,286	2,380	2,541	5,141	4,604	4,139	3,671	1,141	1,105	1,131	1,417	1,013	1,511	1,564	1,438	1,615	1,849	1,948	2,173	2,826	2,585	0	0	0	-	-	-	-	1,143	994	1,033	1,014	1,036	0	0	0
Stock-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-
Shares issues in upon vesting of stock awards
-	-	-	-	-	-	-	-	-	235	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Deferred income tax asset
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares issued in exchange for services
-	-	-	-	-	29	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of deferred finance charges and debt discount associated with notes payable
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares issued out of treasury
-	-	-	-	-	-	-	-	-	-	-	-	-	101	92	75	80	86	96	85	81	64	0	0	0	-	-	-	-	107	38	113	97	60	0	0	0
Change in deferred rent liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	0
Amortization of deferred finance charges and debt discount associated with notes payable
-	-	-	-	-	-	-	-	-	35	73	126	169	236	288	339	396	438	475	506	475	437	549	449	394	336	0	0	0	-	-	-	-	-	-	-	-
Change in deferred rent liability
-	-	-	-	-	-8	-7	31	67	59	52	5	-35	-35	-33	-32	-32	-29	-28	-27	-25	-24	-23	-21	-20	-18	0	0	0	-	-	-	-	-	-	-	-
Loss realized on sale of investment securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-0	-3	-3	-3	0	-1	-1	-45	-24	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net changes in:
Accrued interest on investment securities
-55	-46	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-
Receivable on sale of net operating losses
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Advances, deposits and other current assets
-	-	-	-	-	-	336	116	67	50	0	0	0	-	0	0	0	-	-181	-239	-302	-1	80	28	18	116	0	0	0	-	-	-	-	-	-	-	-
Non cash dividend expense on preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Advances, deposits and other current assets
0	-	-	-	0	-	-	-	-	-115	0	0	0	-	0	0	0	-	-120	359	220	-77	0	0	0	-	-	-	-	-	-	-	-	-	-	0	0
Accounts payable and accrued liabilities
0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable - trade
-	-	-	-	-	-	-	-	-	537	-12	1,023	1,622	48	522	-253	-1,556	-859	-2,135	-654	1,747	1,764	1,917	1,862	-2,078	-887	-467	-2,456	798	-1,344	269	978	392	-538	0	0	0
Other accrued liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,497	-1,276	-62	-1,513	-776	938	202	-811	-92	0	0	0
Accrued liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) operating activities:
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) operating activities:
-19,698	-20,258	-8,556	-8,341	-7,922	-7,041	-17,336	-18,177	-18,167	-16,642	0	0	0	-	-	-	-	-20,830	-23,441	-23,957	-22,466	-21,353	-18,309	-15,134	-16,138	-9,525	-12,037	-14,629	-14,626	-22,144	-20,605	-22,256	-24,097	-22,742	0	0	0
Cash flows from investing activities:
Purchases of investment securities
22,518	23,829	20,737	24,541	22,515	16,973	28,308	18,446	18,444	12,734	0	0	0	-	-	-	-	21,074	21,728	22,821	27,240	29,825	52,913	48,819	63,940	66,323	42,765	45,023	26,330	16,394	0	0	0	-	-	-	0
Proceeds from sale and maturity of investment securities
32,715	30,115	0	0	0	-	-	-	-	1,680	4,515	4,515	4,515	13,635	16,766	24,366	28,198	34,460	44,027	44,216	52,115	42,812	46,553	51,636	41,905	37,194	24,111	14,085	16,289	18,478	12,287	9,534	5,331	395	0	0	0
Purchases of property and equipment
212	349	393	323	253	138	99	95	47	38	34	40	61	62	50	97	88	109	0	0	0	-	-	-	-	-	-	-	-	613	625	761	750	573	0	0	0
Net cash provided by investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
9,984	5,935	7,909	-2,484	-1,889	-1,632	-18,658	-13,541	-18,391	-10,992	0	0	0	-	-	-	-	13,326	21,995	20,837	21,389	9,543	-9,558	-74	-22,042	-29,136	-18,893	-31,187	-10,476	1,470	-4,796	-13,501	-16,637	-11,087	0	0	0
Cash flows from financing activities:
Proceeds from sale of common stock equity, net of issuance costs
11,884	7,844	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,788	13,783	13,771	22,737	15,622	0	0	0	-	-	-	-	48,082	0	0	0
Proceeds from sale of common stock equity, net of issuance costs
-	-	-	-	-	-	-	-	14,862	17,910	9,751	5,597	11,059	6,775	0	0	0	-	-	-	-	-	-	-	-	13,616	0	0	0	-	-	-	-	4,324	0	0	0
Proceeds from exercise of common stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	184	0	0	0	-	-	-	-	-	-	-	-
Proceeds from exercise of common stock warrants
-	-	-	-	-	-	-	-	-	21,140	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal payments on note payable
-	-	-	-	-	-	-	-	-	2,595	3,666	4,705	4,217	4,099	3,982	3,868	3,764	3,654	2,700	1,776	878	10	4,291	4,752	5,057	5,060	794	346	78	110	147	165	159	142	0	0	0
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
11,884	7,844	5,779	4,085	11,101	10,583	36,681	40,844	34,374	36,454	0	0	0	-	-	-	-	4,082	4,462	5,473	4,085	18,777	19,255	18,785	22,420	29,388	35,783	40,129	36,347	15,518	22,587	42,086	47,893	52,836	0	0	0
Decrease in cash and cash equivalents
2,170	-6,478	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Decrease increase in cash and cash equivalents
-	-	-	-	-	-	-	-	-2,184	8,819	-1,499	-8,678	-9,840	-6,640	-3,390	356	6,696	-3,421	3,016	2,353	3,008	6,968	-8,612	3,576	-5,010	-9,272	4,852	-5,687	494	-5,154	-2,814	6,328	7,157	19,006	0	0	0
Supplemental disclosures of cash flow information:
Cash (paid for) received from:
Interest paid
750	760	0	0	0	-	-	-	-	56	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from lease payments
510	485	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash financing and investing activities
Fair value of warrants issued in connection with amendment to modify the GEN-1 earn-out milestone payments
-	400	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Right of use assets
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock issued in lieu of cash bonuses
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Realized and unrealized (gains) losses, net, on investment securities
-83	12	13	98	120	40	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	602	713	819	918	1,013	1,082	1,016	892	851	706	959	637	0	0	0	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0